Results 81 to 90 of about 1,273 (212)

Extracranial neurogenic tumors of the head and neck,

open access: yesBrazilian Journal of Otorhinolaryngology, 2015
INTRODUCTION: Peripheric nerve tumors typically derive from Schwann cells of the peripheral nerve sheet. Since these tumors are uncommon, they should be considered in preoperative differential diagnosis.
Otávio Alberto Curioni   +6 more
doaj   +1 more source

The Tip of the Iceberg: Cutaneous Manifestations of Paediatric Diseases with Neurological Involvement [PDF]

open access: yes, 2015
Introdução: Algumas alterações cutâneas podem ser as primeiras manifestações clínicas de diversas entidades nosológicas com atingimento sistémico. O presente trabalho tem como objectivo rever a semiologia dermatológica relevante no contexto das doenças ...
Afonso, P   +3 more
core  

Reporte de familias con neurofibromatosis y otras enfermedades genéticas Reports of families suffering from neurofibromatosis and other genetic disorders

open access: yesRevista de Ciencias Médicas de Pinar del Río, 2011
La neurofibromatosis tipo 1, es una enfermedad genética que primariamente afecta el desarrollo y crecimiento celular del sistema nervioso, clínicamente se caracteriza por máculas café con leche, neurofibromas, pecas en regiones no expuestas al sol ...
Miladys Orraca Castillo   +2 more
doaj  

Neurofibroma solitario en pared abdominal en paciente sin neurofibromatosis: reporte de caso

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2009
Introducción. Los neurofibromas solitarios son tumores benignos de carácter hereditario, que presentan variantes. Las manifestaciones clínicas cambian según su localización y, ocasionalmente, son similares a las de la neurofibromatosis.
Juan Sebastián Barajas   +1 more
doaj   +1 more source

Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis [PDF]

open access: yes, 2012
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately.
Alona Muzikansky   +53 more
core   +3 more sources

Asymmetry of thalamic hypometabolism on FDG‐PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden

open access: yesJournal of Neuroimaging, Volume 34, Issue 1, Page 138-144, January/February 2024.
Abstract Background and Purpose Thalamic hypometabolism is a consistent finding in brain PET with F‐18 fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). However, the pathophysiology of this metabolic alteration is unknown. We hypothesized that it might be secondary to disturbance of peripheral input to the thalamus by NF1 ...
Cansu Özden   +10 more
wiley   +1 more source

Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross‐Sectional Observational Study

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 1, Page 120-122, January 2025.
Catherine Déry   +7 more
wiley   +1 more source

Pregnancy with neurofibromatosis type II: the enigma continues [PDF]

open access: yes, 2017
Neurofibromatosis type II in pregnancy has variable presentations. The recurrence rate and bilaterality of CP angle tumour is very high. We present a case of bilateral schwanomma diagnosed in midpregnancy, for which patient was operated in second ...
Bose, Simantini   +4 more
core   +2 more sources

Functional regulation of the Neurofibromatosis 2 tumor suppressor merlin [PDF]

open access: yes, 2011
Neurofibromatosis 2 (NF2) is an autosomal dominant disorder manifested by the formation of multiple benign tumors of the nervous system. Affected individuals typically develop bilateral vestibular schwannomas which lead to deafness and balance disorders.
Pehrsson, Minja
core  

Gonadal and gonadosomatic mosaicism in NF1: report of two families

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 3, Page 426-428, March 2024.
Magdalena Seidl‐Philipp   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy